TRIM21 and Sjogren syndrome: Stratifying by autoantibody profile, the hazard ratio of MI after Sjögren's syndrome diagnosis was 1.4 (95% CI 0.8–2.5) in SSA/SSB double‐positive patients, 2.0 (95% CI 1.2–3.4) in SSA/SSB single‐positive patients, and 1.5 (95% CI 0.9–2.5) in SSA/SSB‐negative patients (Table 2).